Skip to content

Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section

Use of Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section in Women With BMI >=30

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01890720
Enrollment
876
Registered
2013-07-02
Start date
2013-09-10
Completion date
2016-12-31
Last updated
2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section; Dehiscence, Complications; Cesarean Section, Complications; Cesarean Section, Wound, Dehiscence, Infection; Cesarean Section, Surgical Wound Infection, Wound; Rupture, Surgery, Cesarean Section

Keywords

Randomized Controlled Trial, Economical Evaluation, Caesarean Section, postoperative wound treatment, surgical site infections, wound infections, infectious morbidity, Negative Pressure Wound Therapy, Incisional Negative Pressure Wound Therapy, Obesity

Brief summary

The purpose of this study is to examine whether obese women (BMI \>= 30) who give birth by caesarean section have a reduced incidence of wound infection and dehiscence when incisional Negative Pressure Wound Therapy is applied prophylactically following caesarean section.

Detailed description

This study is a non-blinded randomised controlled trial and a concurrent Health Economic Evaluation. The study examines the effect on wound healing using incisional Negative Pressure Wound Therapy (iNPWT) compared with standard postoperative dressings in women with a BMI \>= 30, who has a Caesarean Section (CS). We expect to find a lower frequency of wound complications when using iNPWT directly on primary suturing compared to standard postoperative dressings in this high-risk subpopulation. Women, who have given informed consent, will be randomised to either intervention or control group via a computer-generated randomisation program. Elective and emergency CS will be stratified to ensure roughly equal numbers in each category of CS in each arm of the study and permit valid separate and pooled analysis. The analysis will be carried out on an intention to treat basis. The iNPWT or standard postoperative dressings will be applied in theatre immediately following the operation. In the intervention group the therapy will be left in situ for five days corresponding to the date of removal of stitches. In the control group the dressing will be left in situ for at least 24 hours as standard procedure. Women, who do not wish to participate, will be asked for permission to use their data in the analysis.

Interventions

DEVICEiNPWT

The Incisional Negative Pressure Wound Therapy (iNPWT) will be applied over the clean closed incision immediately following the operation (caesarean section). In the intervention group the therapy will be left in situ for five days.

OTHERStandard postoperative wound dressing

A standard wound dressing will be applied over the clean closed incision immediately following the operation (caesarean section). In the control group the dressing will be left in situ for at least 24 hours as standard procedure.

Sponsors

Region of Southern Denmark
CollaboratorOTHER
University of Southern Denmark
CollaboratorOTHER
Hvidovre University Hospital
CollaboratorOTHER
Smith & Nephew, Inc.
CollaboratorINDUSTRY
Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 year * Women who can read and understand Danish * pregestational BMI ≥ 30 kg/m2

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
The incidence of post-CS wound infection in each study groupWithin the first 30 days after surgeryWound infection requiring antibiotic treatment To be able to collect information about symptoms of infection after discharge a self-administered questionnaire will be sent to all participants within 30 days post-CS. Furthermore data on postoperative infections, recorded by diagnoses codes or surgical procedures, will be obtained from the Danish National Patient Registry

Secondary

MeasureTime frameDescription
Readmissions to hospital/contact to the general practitioner on suspicion of infection following caesarean sectionWithin the first 30 days after Caesarean SectionPrimary for the health economic evaluation
Number of Participants with a decreased health-related quality of life score as a measure of satisfaction and tolerabilityWithin the first 30 days after Caesarean SectionA health-related quality of life measure, recorded in Quality Adjusted Life Years at the two interventions. The health-related quality of life score is measured 5 and 30 days post-CS. Primary for the health economic evaluation
Length of the primary and any secondary hospitalizationWithin the first 30 days after Caesarean SectionPrimary for the health economic evaluation
The cosmetic outcome as a measure of satisfactionA 6 and 12 months follow-upThe scar will be evaluated by a plastic surgeon at a clinical examination 6 and 12 months post-CS. After study completion pictures of the scars will be evaluated by two unbiased plastic surgeons, using two predefined scar scales.
Other wound complications after caesarean sectionWithin the first 30 days after Caesarean Sectionwound separation, wound exudate
Antibiotic treatment on suspicion of infection after Caesarean SectionWithin the first 30 days after Caesarean SectionPrimary for the health economic evaluation

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026